Concepedia

Douglas F. Burdi

DF

Statistics

Publications

9

Citations

231

H-Index

9

Active since

1983

Affiliations

Sunovion (United States)(Current)

Vion Pharmaceuticals (United States)

Millennium Engineering and Integration (United States)

Douglas F. Burdi is an author at Sunovion (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1983–2015

9

Publications

9

Synthesis of polyquinanes. 2. The total synthesis of (.+-.)-silphinene: the intramolecular Diels-Alder approach

Daniel D. Sternbach, Jeffrey W. Hughes, Douglas F. Burdi et al. · Journal of the American Chemical Society · 1985 · 50 citations

, , +5

Hydantoin bioisosteres. In vivo active spiro hydroxy acetic acid aldose reductase inhibitors

Christopher A. Lipinski, Charles E. Aldinger, Thomas A. Beyer et al. · Journal of Medicinal Chemistry · 1992 · 40 citations · Full text

, , +6

Design, Synthesis, and Evaluation of Naphthalene-Sulfonamide Antagonists of Human CCR8

Tracy J. Jenkins, Bing Guan, Mingshi Dai et al. · Journal of Medicinal Chemistry · 2007 · 37 citations · Full text

, , +17

Design, Synthesis, and Structure−Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5

Douglas F. Burdi, Rachel Hunt, Lei Fan et al. · Journal of Medicinal Chemistry · 2010 · 31 citations · Full text

, , +16

Small molecule antagonists of the CC chemokine receptor 4 (CCR4)

Douglas F. Burdi, Shannon Chi, Karen Mattia et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 23 citations · Full text

, , +14

1–5 of 9